AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CHATTEM, INC. DBA OPELLA · Manufacturer of consumer healthcare products.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $40,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.